These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8959478)

  • 1. Effects of 'Seroquel' (quetiapine) on platelet serotonin-2 binding in schizophrenia.
    Faustman WO; Ringo DL; Lauriello J; Lim KO; Pfefferbaum A
    J Clin Psychopharmacol; 1996 Dec; 16(6):464-6. PubMed ID: 8959478
    [No Abstract]   [Full Text] [Related]  

  • 2. A positron emission tomography study of quetiapine in schizophrenia: a preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancy.
    Kapur S; Zipursky R; Jones C; Shammi CS; Remington G; Seeman P
    Arch Gen Psychiatry; 2000 Jun; 57(6):553-9. PubMed ID: 10839333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicentre, double-blind, randomized comparison of quetiapine (ICI 204,636, 'Seroquel') and haloperidol in schizophrenia.
    Copolov DL; Link CG; Kowalcyk B
    Psychol Med; 2000 Jan; 30(1):95-105. PubMed ID: 10722180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group.
    Small JG; Hirsch SR; Arvanitis LA; Miller BG; Link CG
    Arch Gen Psychiatry; 1997 Jun; 54(6):549-57. PubMed ID: 9193196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group.
    Arvanitis LA; Miller BG
    Biol Psychiatry; 1997 Aug; 42(4):233-46. PubMed ID: 9270900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attentional improvement following quetiapine fumarate treatment in schizophrenia.
    Sax KW; Strakowski SM; Keck PE
    Schizophr Res; 1998 Oct; 33(3):151-5. PubMed ID: 9789907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo serotonin 5-HT(2A) receptor occupancy and quetiapine.
    Jones HM; Travis MJ; Mulligan R; Visvikis D; Gacinovic S; Ell PJ; Kerwin RW; Pilowsky LS
    Am J Psychiatry; 2000 Jan; 157(1):148. PubMed ID: 10618043
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of depressive mood in schizophrenia with the atypical antipsychotic quetiapine.
    Khouzam HR
    Depress Anxiety; 2000; 11(2):80-2. PubMed ID: 10812533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time course of central nervous dopamine-D2 and 5-HT2 receptor blockade and plasma drug concentrations after discontinuation of quetiapine (Seroquel) in patients with schizophrenia.
    Gefvert O; Bergström M; Långström B; Lundberg T; Lindström L; Yates R
    Psychopharmacology (Berl); 1998 Jan; 135(2):119-26. PubMed ID: 9497016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The use of Seroquel in schizophrenia].
    Chakhava VO
    Zh Nevrol Psikhiatr Im S S Korsakova; 2000; 100(9):63-4. PubMed ID: 11026140
    [No Abstract]   [Full Text] [Related]  

  • 11. Medical-claims databases in the design of a health-outcomes comparison of quetiapine ('Seroquel') and usual-care antipsychotic medication.
    Hong WW; Rak IW; Ciuryla VT; Wilson AM; Kylstra JW; Meltzer HY; Carpenter WT; Lehman A; Arvanitis LA
    Schizophr Res; 1998 Jun; 32(1):51-8. PubMed ID: 9690334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of quetiapine in adolescents with schizophrenia investigated in a 6-week, double-blind, placebo-controlled trial.
    Findling RL; McKenna K; Earley WR; Stankowski J; Pathak S
    J Child Adolesc Psychopharmacol; 2012 Oct; 22(5):327-42. PubMed ID: 23083020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of quetiapine and chlorpromazine in the treatment of schizophrenia.
    Peuskens J; Link CG
    Acta Psychiatr Scand; 1997 Oct; 96(4):265-73. PubMed ID: 9350955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroquel: a putative atypical antipsychotic drug with serotonin- and dopamine-receptor antagonist properties. Preclinical and early clinical trials in schizophrenia.
    J Clin Psychiatry; 1995 Sep; 56(9):438-45. PubMed ID: 7665549
    [No Abstract]   [Full Text] [Related]  

  • 15. The scourge of EPS: have atypical antipsychotics solved the problem?
    J Clin Psychiatry; 2000 Dec; 61(12):955-62. PubMed ID: 11206607
    [No Abstract]   [Full Text] [Related]  

  • 16. The effects of concomitant phenytoin administration on the steady-state pharmacokinetics of quetiapine.
    Wong YW; Yeh C; Thyrum PT
    J Clin Psychopharmacol; 2001 Feb; 21(1):89-93. PubMed ID: 11199955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroquel (ICI 204 636), a putative "atypical" antipsychotic, in schizophrenia with positive symptomatology: results of an open clinical trial and changes of neuroendocrinological and EEG parameters.
    Wetzel H; Szegedi A; Hain C; Wiesner J; Schlegel S; Benkert O
    Psychopharmacology (Berl); 1995 May; 119(2):231-8. PubMed ID: 7659771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolactin elevation with quetiapine.
    Alexiadis M; Whitehorn D; Woodley H; Kopala L
    Am J Psychiatry; 2002 Sep; 159(9):1608-9. PubMed ID: 12202292
    [No Abstract]   [Full Text] [Related]  

  • 19. A case of depersonalization-derealization syndrome during treatment with quetiapine.
    Sarkar J; Jones N; Sullivan G
    J Psychopharmacol; 2001 Sep; 15(3):209-11. PubMed ID: 11565631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agranulocytosis and granulocytopenia associated with quetiapine.
    Ruhé HG; Becker HE; Jessurun P; Marees CH; Heeringa M; Vermeulen HD
    Acta Psychiatr Scand; 2001 Oct; 104(4):311-3; discussion 313-4. PubMed ID: 11722307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.